Activation of GABAA and opioid receptors reduce penile erection induced by hexarelin peptides

Pharmacology Biochemistry and Behavior

Volumn 76, Issue 3-4, 2003, Pages 563-570

  Succu, Salvatora ^a   Mascia, Maria Stefania ^a   Melis, Tiziana ^a   Melis, Maria Rosaria ^a   Deghenghi, Romano ^a   Argiolas, Antonio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

GABA; Hexarelin analogue peptides; Morphine; Muscimol; Naloxone; Nitric oxide (NO); Oxytocin; Penile erection

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; BICUCULLINE; HEXARELIN; MORPHINE; MUSCIMOL; NALOXONE; NITROGEN DERIVATIVE; NITROGEN DIOXIDE; OPIATE AGONIST; OPIATE RECEPTOR; PEPTIDE DERIVATIVE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; EP 80661; NARCOTIC AGENT; NITRATE; NITRIC OXIDE; OLIGOPEPTIDE; PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DIALYSATE; DOSE RESPONSE; HYPOTHALAMUS; INJECTION; MALE; MICRODIALYSIS; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; THALAMUS MIDLINE NUCLEUS; ANIMAL; ANTERIOR HYPOTHALAMUS; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MICROINJECTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; MALE; MICRODIALYSIS; MICROINJECTIONS; MORPHINE; MUSCIMOL; NARCOTICS; NITRATES; NITRIC OXIDE; OLIGOPEPTIDES; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PENILE ERECTION; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, OPIOID;

EID: 0344413524     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.09.012     Document Type: Article

References (42)

1. 2) in rat anterior pituitary cells. Endocrinology. 132:1993;1286-1291.
2. Argiolas A., Melis M.R. Neuromodulation of penile erection: an overview of the role of neurotransmitters and neuropeptides. Prog. Neurobiol. 47:1995;235-255.
3. Bankowski K., Manning M., Seto J., Halder J., Sawyer W.H. Design and synthesis of potent in vivo antagonists of oxytocin. Int. J. Pept. Prot. Res. 16:1980;382-391.
4. Bicknell R.J., Leng G., Lincoln D.W., Russel J.A. Naloxone excites oxytocin neurones in the supraoptic nucleus of lactacting rats after chronic morphine treatment. J. Physiol. (Lond.). 396:1988;297-317.
5. Bisi G., Podio V., Valetto M.R., Broglio F., Bertuccio G., Aimaretti G. et al. Cardiac effects of hexarelin in hypopituitary adults. Eur. J. Pharmacol. 381:1999;31-38.
6. Bisset G.W., Chowdrey H.S., Fairhall K.M., Gunn L.K. Central inhibition by gamma-aminobutyric acid and muscimol of the release of vasopressin and oxytocin by an osmotic stimulus in the rat. Br. J. Pharmacol. 99:1990;529-535.
7. Bodart V., Bouchard J.F., McNicoll N., Escher E., Carriere P., Ghigo E. et al. Identification and characterisation of a new growth hormone-releasing peptide receptor in the heart. Circ. Res. 1999;796-802.
8. Boubada C., Szabò K., Tasker G. Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J. Neurosci. 15:1996;7151-7160.
9. Clarke G., Wood P., Merrick L., Lincoln D.W. Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurons. Nature. 282:1979;746-748.
10. Deghenghi R. Growth hormone-releasing peptides. Bercu B.B., Walker R.F. Growth Hormone Secretagogues. 1996;85-102 Springer, New York.
11. Deghenghi R., Cananzi M.M., Torsello A., Battisti C., Muller E.E., Locatelli V. GH-releasing properties of hexarelin, a new growth hormone-releasing peptide, in infant and adult rats. Life Sci. 54:1994;1321-1328.
12. Giuliano F., Argiolas A., Bernabè J., Mevel K., Alexandre L., Deghenghi R. Comparison of the proerectile effect of two hexarelin analogues, EP 80661 and EP 91072, with apomorphine after intravenous or intraparaventricular nucleus delivery in anesthetized rats. Int. J. Impot. Res. 13(Suppl. 4):2001;15-16.
13. Hosoda H., Kojima M., Matsuo H., Kangawa K. Purification and characterization of rat des-Gln14-ghrelin, a second endogenous ligand for growth hormone secretagogue receptor. J. Biol. Chem. 275:2000;21995-22000.
14. Jourdain P., Dupouy B., Bonhomme R., Poulain D.A., Israel J.M., Theodosis D.T. Visualization of local afferent inputs to magnocellular oxytocin neurons in vitro. Eur. J. Neurosci. 11:1999;1960-1972.
15. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature. 402:1999;656-660.
16. Locatelli V., Rossoni G., Schweiger F., Torsello A., De Gennaro Colonna V., Bernareggi R.et al. Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology. 140:1999;4024-4031.
17. McCleskey E.W., Fox A.P., Feldman D.H., Cruz L.J., Olivera B.M., Xien R.W.et al. ω-Conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc. Natl. Acad. Sci. U S A. 84:1987;4327-4331.
18. A receptors in the paraventricular nucleus: involvement of nitric oxide. Eur. J. Neurosci. 15:2002;852-860.
19. Melis M.R., Succu S., Argiolas A. Dopamine agonists increase nitric oxide production in the paraventricular nucleus of the hypothalamus: correlation with penile erection and yawning. Eur. J. Neurosci. 8:1996;2056-2063.
20. Melis M.R., Succu S., Iannucci U., Argiolas A. Oxytocin increases nitric oxide production in the paraventricular nucleus of the hypothalamus: correlation with penile erection and yawning. Regul. Pept. 69:1997;105-112.
21. Melis M.R., Succu S., Iannucci U., Argiolas A. N-Methyl-D-aspartic acid-induced penile erection and yawning: role of hypothalamic paraventricular nitric oxide. Eur. J. Pharmacol. 328:1997;115-123.
22. Melis M.R., Succu S., Mauri A., Argiolas A. Nitric oxide production is increased in the paraventricular nucleus of the hypothalamus of male rats during non-contact penile erections and copulation. Eur. J. Neurosci. 10:1998;1968-1974.
23. 8-vasotocin reduces non-contact penile erections in male rats. Neurosci. Lett. 265:1999;171-174.
24. Melis M.R., Succu S., Spano M.S., Argiolas A. Morphine injected into the paraventricular nucleus of the hypothalamus prevents non-contact erections and impairs copulation: involvement of nitric oxide. Eur. J. Neurosci. 11:1999;1857-1864.
25. Melis M.R., Spano M.S., Succu S., Torsello A., Locatelli V., Muller E.E.et al. EP 60761- and EP 50885-induced penile erection: structure-activity studies and comparison with apomorphine, oxytocin and N-methyl-D-aspartic acid. Int. J. Impot. Res. 12:2000;255-262.
26. Melis M.R., Succu S., Spano M.S., Deghenghi R., Argiolas A. EP 91073 prevents EP-80661-induced penile erection: new evidence for the existence of specific EP peptide receptors mediating penile erection. Neuropharmacology. 41:2001;254-262.
27. Melis M.R., Succu S., Spano M.S., Torsello A., Locatelli V., Muller E.E.et al. Penile erection induced by EP 80661 and other hexarelin peptide analogues: role of paraventricular nitric oxide. Eur. J. Pharmacol. 411:2001;305-310.
28. Melis M.R., Mascia M.S., Succu S., Torsello A., Muller E.E., Deghenghi R.et al. Ghrelin injected into the paraventricular nucleus of male rats induces feeding but not penile erection. Neurosci. Lett. 329:2002;339-343.
29. Muccioli G., Ghe C., Ghigo M.C., Papotti M., Arvat E., Boghen M.F.et al. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol. 157:1999;99-106.
30. Muhlethaler M., Gahwiler B.H., Dreifuss J.J. Enkephalin-induced inhibition of hypothalamic paraventricular neurons. Brain Res. 197:1980;264-268.
31. Muller E.E., Locatelli V., Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol. Rev. 79:1999;511-607.
32. Pellegrino L.J., Cushman A.J. A Stereotaxic Atlas of The Rat Brain. 1971;Meredith, New York.
33. Pittman Q.J., Hatton J.D., Bloom F.E. Morphine and opioid peptides reduce paraventricular neuronal activity: study on the rat hypothalamic slice preparation. Proc. Natl. Acad. Sci. U S A. 77:1980;5525-5531.
34. Pong S.S., Chaung L.-Y.P., Dean D., Nargund R.P., Patchett A.A., Smith R.G. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol. Endocrinol. 10:1996;57-61.
35. Rees D.D., Palmer R.M.J., Schulz R., Hodson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101:1990;746-752.
36. Roland B.L., Sawchenko P.E. Local origin of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J. Comp. Neurol. 332:1993;123-143.
37. Sartor O., Bowers C.Y., Chang D. Parallel studies of His-D-Trp-Ala-Trp-D- Phe-LysNH2 in rat primary pituitary cell monolayer culture. Endocrinology. 116:1985;952-957.
38. Smith R.G., Palyha O.C., Feighner S.D., Tan C.P., McKee K.K., Hreniuk D.L.et al. Growth hormone releasing substances: types and their receptors. Horm. Res. (Suppl. S3):1999;1-8.
39. Succu S., Spano M.S., Melis M.R., Argiolas A. Different effects of ω-conotoxin on penile erection, yawning and paraventricular nitric oxide in male rats. Eur. J. Pharmacol. 359:1998;19-26.
40. Torsello A., Luoni M., Schweiger F., Grilli R., Guidi M., Bresciani E.et al. Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release. Eur. J. Pharmacol. 360:1998;123-129.
41. Voisin L.D., Herbison A.E., Poulain D.A. Central inhibitory effect of muscimol and bicuculline on the milk ejection reflex in the anaesthetized rat. J. Physiol. (Lond.). 483:1995;211-224.
42. Wuarin J.-P., Dubois-Dauphin M., Raggenbass M., Dreifuss J.J. Effect of opioid peptides on the paraventricular nucleus of the guinea pig hypothalamus is mediated by μ-type opioid receptors. Brain Res. 445:1988;289-296.